Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


The Fertility Show


 

A gene switch for better heart healing in mice

22 April 2013

By Emma Stoye

Appeared in BioNews 701

Researchers have identified a gene that regulates the regeneration of adult heart cells. The discovery could provide a new approach to treating heart failure in humans.

Most body tissues can repair themselves, with the help of nearby dividing cells. Cuts on the skin, for example, heal easily within a couple of days. But cells in the heart lose the ability to divide soon after birth. This means that the death of heart cells, brought on by a heart attack or other conditions, can lead to heart failure, where the heart can no longer pump enough blood around the body.

Now, scientists are one step closer to understanding why this happens. An international team led by Dr Hesham Sadek of the University of Texas, US, found that the expression of a gene called Meis1 increased in mice after they were born. Levels of Meis1 increased steadily for seven days after birth, after which the heart became unable to self-heal.

When they disabled the gene, heart cells kept on dividing in the mice well into adulthood, and their hearts were found to contain more cells than control mice with the intact gene. However, when Meis1 was overexpressed in newborn mice, their hearts failed to heal after being damaged.

'Meis1 is a transcription factor, which acts like a software program that has the ability to control the function of other genes', explained Dr Sadek. 'In this case, we found that Meis1 controls several genes that normally act as brakes on cell division'.

The findings provide a better understanding of the genes controlling heart development, and hint at a possible gene therapy approach to treating human heart failure. 'Meis1 could possibly be used as an on/off switch for making adult heart cells divide. If done successfully, this ability could introduce a new era in treatment for heart failure', says Dr Sadek.

But any new treatment for human heart conditions is likely to be a long way off, as the study only featured mice. Professor Jeremy Pearson, associate medical director at the British Heart Foundation, told the Telegraph: 'This [research] opens up the exciting prospect that blocking Meis1 will encourage heart muscle to regenerate and repair heart function after a heart attack. Further research is now needed to confirm this, and to design ways of blocking Meis1 that could be used clinically'.

The study was published last week in the journal Nature.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

18 November 2013 - by Siobhan Chan 
Heart failure can be reversed using gene therapy, with the effect being amplified when two genes are used together, a study in pigs has found...
09 September 2013 - by Siobhan Chan 
The first patients from two separate ongoing studies have been treated using gene and stem cell therapies to repair damage caused by heart attacks...
27 August 2013 - by Lanay Tierney 
Researchers have concocted a 'gene cocktail' that may help to turn scar tissue into functioning cardiac cells after a heart attack...
19 August 2013 - by Dr Katie Howe 
A mouse heart was able to contract again after its own cells were removed and replaced with human stem cells, a study in Nature Communications reports...
03 June 2013 - by Matthew Young 
A gene linked to the congenital heart disease known as 'hole in the heart' has been discovered by UK researchers....

08 April 2013 - by Dr Greg Ball 
Genes that influence the so-called 'biological age' of cells may also influence susceptibility to many age-related diseases...
11 February 2013 - by Nina Chohan 
A mutation in the gene for lipoprotein(a), a type of cholesterol, is linked to aortic valve disease, according to a large international study...
12 November 2012 - by Dr Nicola Davis 
Stem cells obtained from donors have been used in clinical trials to effectively treat damage caused by heart attacks. The trial found that donor stem cells were 'just as safe' as stem cells derived from the person being treated....
11 June 2012 - by Dr Rebecca Hill 
A previously unidentified type of stem cell, usually dormant in blood vessels, is at the heart of vascular disease, according to researchers...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Jacques Cohen

Dr Anna Smajdor

Dr Andy Greenfield

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation